Search Results - "Mittakanti, Harsha R."

Contemporary Use of Partial Nephrectomy: are Older Patients with Impaired Kidney Function Being Left behind? by Leppert, John T., M.D. M.S, Mittakanti, Harsha R., M.D, Thomas, I-Chun, M.S, Lamberts, Remy W., M.D, Sonn, Geoffrey A., M.D, Chung, Benjamin I., M.D, Skinner, Eila C., M.D, Wagner, Todd H., Ph.D, Chertow, Glenn M., M.D. M.P.H, Brooks, James D., M.D

“…Abstract Objectives To assess whether patient factors, such as age and preoperative kidney function, were associated with receipt of partial in a national…”
Get full text

Transperitoneal vs. retroperitoneal robotic partial nephrectomy: a matched-paired analysis by Mittakanti, Harsha R., Heulitt, Gerald, Li, Hsin-Fang, Porter, James R.

“…Purpose When performing robotic nephron-sparing surgery (NSS) for renal tumors, either a transperitoneal approach or retroperitoneal approach can be utilized…”
Get full text

Robotic retroperitoneal lymph node dissection for testicular cancer: feasibility and latest outcomes by Mittakanti, Harsha R, Porter, James R

“…PURPOSE OF REVIEWRobotic-assisted laparoscopic retroperitoneal lymph node dissection (R-RPLND) is gaining acceptance as an alternative to open and laparoscopic…”
Get full text

Robot-assisted laparoscopic retroperitoneal lymph node dissection: a minimally invasive surgical approach for testicular cancer by Mittakanti, Harsha R, Porter, James R

“…Retroperitoneal lymph node dissection (RPLND) can been employed as primary treatment for stage I non-seminomatous germ cell tumor (NSGCT) as well as for…”
Get full text

Unplanned Emergency Department Visits and Hospital Admissions Following Ureteroscopy: Do Ureteral Stents Make a Difference? by Mittakanti, Harsha R., Conti, Simon L., Pao, Alan C., Chertow, Glenn M., Liao, Joseph C., Leppert, John T., Elliott, Christopher S.

“…To evaluate unplanned medical visits within the early postoperative period after ureteroscopy in patients with and without ureteral stent placement. We…”
Get full text

Priapism caused by “Rhino 7 Platinum 3000” an over-the-counter male enhancement supplement by Mittakanti, Harsha R., Elliott, Christopher S.

“…Male enhancement and erectile dysfunction supplements are typically non-Food and Drug Administration (FDA) approved and readily available for purchase by…”
Get full text

The Research Implications of Prostate Specific Antigen Registry Errors: Data from the Veterans Health Administration by Guo, David P., Thomas, I-Chun, Mittakanti, Harsha R., Shelton, Jeremy B., Makarov, Danil V., Skolarus, Ted A., Cooperberg, Matthew R., Sonn, Geoffrey A., Chung, Benjamin I., Brooks, James D., Leppert, John T.

“…We sought to characterize the effects of prostate specific antigen registry errors on clinical research by comparing cohorts based on cancer registry prostate…”
Get full text

Accuracy of Prostate-Specific Antigen Values in Prostate Cancer Registries by Mittakanti, Harsha R, Thomas, I-Chun, Shelton, Jeremy B, Makarov, Danil V, Skolarus, Ted A, Cooperberg, Matthew R, Chung, Benjamin I, Sonn, Geoffrey A, Brooks, James D, Leppert, John T

Get full text

Editorial Comment by Mittakanti, Harsha R., Leppert, John T.

Get full text

PD35-12 UNPLANNED EMERGENCY DEPARTMENT VISITS AND HOSPITAL ADMISSIONS FOLLOWING URETEROSCOPY: DO URETERAL STENTS MAKE A DIFFERENCE? by Mittakanti, Harsha R, Conti, Simon, Pao, Alan C, Liao, Joseph, Leppert, John T, Elliott, Christopher S

Get full text

Editorial Comment by Mittakanti, Harsha R., M.D, Leppert, John T., M.D., M.S

Get full text

Editorial Comment by Mittakanti, Harsha R, Leppert, John T

Get full text

Editorial Comment by Mittakanti, Harsha R, Leppert, John T

Get full text

PD35-12 UNPLANNED EMERGENCY DEPARTMENT VISITS AND HOSPITAL ADMISSIONS FOLLOWING URETEROSCOPY: DO URETERAL STENTS MAKE A DIFFERENCE? by Mittakanti, Harsha R., Conti, Simon, Pao, Alan C., Liao, Joseph, Leppert, John T., Elliott, Christopher S.

Get full text